Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Persistent primary cytomegalovirus infection in a kidney transplant recipient: Multi-drug resistant and compartmentalized infection leading to graft loss.

Andrei G, Van Loon E, Lerut E, Victoor J, Meijers B, Bammens B, Sprangers B, Gillemot S, Fiten P, Opdenakker G, Lagrou K, Kuypers D, Snoeck R, Naesens M.

Antiviral Res. 2019 Aug;168:203-209. doi: 10.1016/j.antiviral.2019.06.004. Epub 2019 Jun 15.

PMID:
31212020
2.

Clinical courses and complications of young adults with Autosomal Recessive Polycystic Kidney Disease (ARPKD).

Burgmaier K, Kilian S, Bammens B, Benzing T, Billing H, Büscher A, Galiano M, Grundmann F, Klaus G, Mekahli D, Michel-Calemard L, Milosevski-Lomic G, Ranchin B, Sauerstein K, Schaefer S, Shroff R, Sterenborg R, Verbeeck S, Weber LT, Wicher D, Wühl E, Dötsch J, Schaefer F, Liebau MC.

Sci Rep. 2019 May 28;9(1):7919. doi: 10.1038/s41598-019-43488-w.

3.

Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients.

Evenepoel P, Claes K, Meijers B, Laurent MR, Bammens B, Naesens M, Sprangers B, Pottel H, Cavalier E, Kuypers D.

Kidney Int. 2019 Jun;95(6):1461-1470. doi: 10.1016/j.kint.2018.12.024. Epub 2019 Mar 4.

PMID:
30922664
4.

A distinct bone phenotype in ADPKD patients with end-stage renal disease.

Evenepoel P, Claes K, Cavalier E, Meijers B, Stenvinkel P, Behets G, Jankowska M, D'Haese P, Bammens B.

Kidney Int. 2019 Feb;95(2):412-419. doi: 10.1016/j.kint.2018.09.018.

PMID:
30665572
5.

Unmet needs and challenges for follow-up and treatment of autosomal dominant polycystic kidney disease: the paediatric perspective.

De Rechter S, Bammens B, Schaefer F, Liebau MC, Mekahli D.

Clin Kidney J. 2018 Dec;11(Suppl 1):i14-i26. doi: 10.1093/ckj/sfy088. Epub 2018 Dec 17. Review.

6.

Poor Vitamin K Status Is Associated With Low Bone Mineral Density and Increased Fracture Risk in End-Stage Renal Disease.

Evenepoel P, Claes K, Meijers B, Laurent M, Bammens B, Naesens M, Sprangers B, Pottel H, Cavalier E, Kuypers D.

J Bone Miner Res. 2019 Feb;34(2):262-269. doi: 10.1002/jbmr.3608. Epub 2018 Nov 14.

PMID:
30427544
7.

Natural history of mineral metabolism, bone turnover and bone mineral density in de novo renal transplant recipients treated with a steroid minimization immunosuppressive protocol.

Evenepoel P, Claes K, Meijers B, Laurent MR, Bammens B, Naesens M, Sprangers B, Cavalier E, Kuypers D.

Nephrol Dial Transplant. 2018 Oct 17. doi: 10.1093/ndt/gfy306. [Epub ahead of print]

PMID:
30339234
8.

Oxidative stress in chronic kidney disease.

Daenen K, Andries A, Mekahli D, Van Schepdael A, Jouret F, Bammens B.

Pediatr Nephrol. 2019 Jun;34(6):975-991. doi: 10.1007/s00467-018-4005-4. Epub 2018 Aug 13. Review.

9.

Oxidative stress in autosomal dominant polycystic kidney disease: player and/or early predictor for disease progression?

Andries A, Daenen K, Jouret F, Bammens B, Mekahli D, Van Schepdael A.

Pediatr Nephrol. 2019 Jun;34(6):993-1008. doi: 10.1007/s00467-018-4004-5. Epub 2018 Aug 13.

10.

Renal progression factors in young patients with tuberous sclerosis complex: a retrospective cohort study.

Janssens P, Van Hoeve K, De Waele L, De Rechter S, Claes KJ, Van de Perre E, Wissing KM, Bammens B, Jansen A, Mekahli D.

Pediatr Nephrol. 2018 Nov;33(11):2085-2093. doi: 10.1007/s00467-018-4003-6. Epub 2018 Jul 9.

PMID:
29987458
11.

3DUS as an alternative to MRI for measuring renal volume in children with autosomal dominant polycystic kidney disease.

Breysem L, De Rechter S, De Keyzer F, Smet MH, Bammens B, Van Dyck M, Hofmans M, Oyen R, Levtchenko E, Mekahli D.

Pediatr Nephrol. 2018 May;33(5):827-835. doi: 10.1007/s00467-017-3862-6. Epub 2018 Jan 6.

PMID:
29306987
12.

Clinicians' attitude towards family planning and timing of diagnosis in autosomal dominant polycystic kidney disease.

De Rechter S, Kringen J, Janssens P, Liebau MC, Devriendt K, Levtchenko E, Bergmann C, Jouret F, Bammens B, Borry P, Schaefer F, Mekahli D.

PLoS One. 2017 Sep 29;12(9):e0185779. doi: 10.1371/journal.pone.0185779. eCollection 2017.

13.

Cladophialophora bantiana osteomyelitis in a renal transplant patient.

Desmet S, Smets L, Lagrou K, Derdelinckx I, Neyt J, Maertens J, Sciot R, Demaerel P, Bammens B.

Med Mycol Case Rep. 2016 Jul 9;12:17-20. doi: 10.1016/j.mmcr.2016.07.002. eCollection 2016 Jun.

14.

Decreased Circulating Sclerostin Levels in Renal Transplant Recipients With Persistent Hyperparathyroidism.

Evenepoel P, Claes K, Viaene L, Bammens B, Meijers B, Naesens M, Sprangers B, Kuypers D.

Transplantation. 2016 Oct;100(10):2188-93. doi: 10.1097/TP.0000000000001311.

PMID:
27379556
15.

The influence of renal transplantation on retained microbial-human co-metabolites.

Poesen R, Evenepoel P, de Loor H, Bammens B, Claes K, Sprangers B, Naesens M, Kuypers D, Augustijns P, Meijers B.

Nephrol Dial Transplant. 2016 Oct;31(10):1721-1729. Epub 2016 Mar 8.

PMID:
26961998
16.

Phosphorus metabolism in peritoneal dialysis- and haemodialysis-treated patients.

Evenepoel P, Meijers BK, Bammens B, Viaene L, Claes K, Sprangers B, Naesens M, Hoekstra T, Schlieper G, Vanderschueren D, Kuypers D.

Nephrol Dial Transplant. 2016 Sep;31(9):1508-14. doi: 10.1093/ndt/gfv414. Epub 2016 Jan 31.

PMID:
26908778
17.

Sclerostin Serum Levels and Vascular Calcification Progression in Prevalent Renal Transplant Recipients.

Evenepoel P, Goffin E, Meijers B, Kanaan N, Bammens B, Coche E, Claes K, Jadoul M.

J Clin Endocrinol Metab. 2015 Dec;100(12):4669-76. doi: 10.1210/jc.2015-3056. Epub 2015 Oct 27.

PMID:
26505822
18.

The effect of anastomosis time on outcome in recipients of kidneys donated after brain death: a cohort study.

Heylen L, Naesens M, Jochmans I, Monbaliu D, Lerut E, Claes K, Heye S, Verhamme P, Coosemans W, Bammens B, Evenepoel P, Meijers B, Kuypers D, Sprangers B, Pirenne J.

Am J Transplant. 2015 Nov;15(11):2900-7. doi: 10.1111/ajt.13397.

19.

Association of HO-1 (GT)n Promoter Polymorphism and Cardiovascular Disease: A Reanalysis of the Literature.

Daenen KE, Martens P, Bammens B.

Can J Cardiol. 2016 Feb;32(2):160-8. doi: 10.1016/j.cjca.2015.06.006. Epub 2015 Jun 18. Review.

PMID:
26483091
20.

Purple Urine Bag Syndrome in Two Elderly Men with Urinary Tract Infection.

Van Keer J, Detroyer D, Bammens B.

Case Rep Nephrol. 2015;2015:746981. doi: 10.1155/2015/746981. Epub 2015 Aug 17.

21.

Proteinuria as a Noninvasive Marker for Renal Allograft Histology and Failure: An Observational Cohort Study.

Naesens M, Lerut E, Emonds MP, Herelixka A, Evenepoel P, Claes K, Bammens B, Sprangers B, Meijers B, Jochmans I, Monbaliu D, Pirenne J, Kuypers DR.

J Am Soc Nephrol. 2016 Jan;27(1):281-92. doi: 10.1681/ASN.2015010062. Epub 2015 Jul 7.

22.

How to isolate a patient with Cladophialophora bantiana infection? An opinion.

Saegeman V, Bammens B, De Munter P, Neyt J, Cossey V, Schuermans A.

J Hosp Infect. 2015 Sep;91(1):89-90. doi: 10.1016/j.jhin.2015.05.005. Epub 2015 Jun 9. No abstract available.

PMID:
26122625
23.

Lanreotide Reduces Liver Volume, But Might Not Improve Muscle Wasting or Weight Loss, in Patients With Symptomatic Polycystic Liver Disease.

Temmerman F, Ho TA, Vanslembrouck R, Coudyzer W, Billen J, Dobbels F, van Pelt J, Bammens B, Pirson Y, Nevens F.

Clin Gastroenterol Hepatol. 2015 Dec;13(13):2353-9.e1. doi: 10.1016/j.cgh.2015.05.039. Epub 2015 Jun 12.

PMID:
26073493
24.

Invasive aspergillosis after kidney transplant: case-control study.

Heylen L, Maertens J, Naesens M, Van Wijngaerden E, Lagrou K, Bammens B, Claes K, Evenepoel P, Meijers B, Kuypers D, Sprangers B.

Clin Infect Dis. 2015 May 15;60(10):1505-11. doi: 10.1093/cid/civ103. Epub 2015 Feb 13.

PMID:
25681376
25.

Microscopic nephrocalcinosis in chronic kidney disease patients.

Evenepoel P, Daenen K, Bammens B, Claes K, Meijers B, Naesens M, Sprangers B, Kuypers D, Lerut E.

Nephrol Dial Transplant. 2015 May;30(5):843-8. doi: 10.1093/ndt/gfu400. Epub 2015 Jan 13.

PMID:
25586405
26.

The histology of kidney transplant failure: a long-term follow-up study.

Naesens M, Kuypers DR, De Vusser K, Evenepoel P, Claes K, Bammens B, Meijers B, Sprangers B, Pirenne J, Monbaliu D, Jochmans I, Lerut E.

Transplantation. 2014 Aug 27;98(4):427-35. doi: 10.1097/TP.0000000000000183.

PMID:
25243513
27.

Development and validation of a polycystic liver disease complaint-specific assessment (POLCA).

Temmerman F, Dobbels F, Ho TA, Pirson Y, Vanslembrouck R, Coudyzer W, Bammens B, van Pelt J, Pirenne J, Nevens F.

J Hepatol. 2014 Nov;61(5):1143-50. doi: 10.1016/j.jhep.2014.06.024. Epub 2014 Jul 1.

PMID:
24996047
28.

Time course of asymmetric dimethylarginine and symmetric dimethylarginine levels after successful renal transplantation.

Claes KJ, Bammens B, Kuypers DR, Meijers B, Naesens M, Sprangers B, Vanrenterghem Y, Lerut E, de Loor H, Evenepoel P.

Nephrol Dial Transplant. 2014 Oct;29(10):1965-72. doi: 10.1093/ndt/gfu219. Epub 2014 Jun 23.

PMID:
24957811
29.

Postimplantation X-ray parameters predict functional catheter problems in peritoneal dialysis.

Bammens B, Peeters D, Jaekers J, Claes KJ, Evenepoel P, Kuypers D, Meijers B, Naesens M, Vanrenterghem Y, Monbaliu D.

Kidney Int. 2014 Nov;86(5):1001-6. doi: 10.1038/ki.2014.203. Epub 2014 Jun 18.

30.

Cardiovascular disease relates to intestinal uptake of p-cresol in patients with chronic kidney disease.

Poesen R, Viaene L, Verbeke K, Augustijns P, Bammens B, Claes K, Kuypers D, Evenepoel P, Meijers B.

BMC Nephrol. 2014 Jun 9;15:87. doi: 10.1186/1471-2369-15-87.

31.

Soluble urokinase receptor is a biomarker of cardiovascular disease in chronic kidney disease.

Meijers B, Poesen R, Claes K, Dietrich R, Bammens B, Sprangers B, Naesens M, Storr M, Kuypers D, Evenepoel P.

Kidney Int. 2015 Jan;87(1):210-6. doi: 10.1038/ki.2014.197. Epub 2014 Jun 4.

32.

Diabetic muscle infarction: a rare cause of acute limb pain in dialysis patients.

De Vlieger G, Bammens B, Claus F, Vos R, Claes K.

Case Rep Nephrol. 2013;2013:931523. doi: 10.1155/2013/931523. Epub 2013 May 7.

33.

The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis.

Meijers B, Maas RJ, Sprangers B, Claes K, Poesen R, Bammens B, Naesens M, Deegens JK, Dietrich R, Storr M, Wetzels JF, Evenepoel P, Kuypers D.

Kidney Int. 2014 Mar;85(3):636-40. doi: 10.1038/ki.2013.505. Epub 2014 Jan 8.

34.

Intrarenal resistive index after renal transplantation.

Naesens M, Heylen L, Lerut E, Claes K, De Wever L, Claus F, Oyen R, Kuypers D, Evenepoel P, Bammens B, Sprangers B, Meijers B, Pirenne J, Monbaliu D, de Jonge H, Metalidis C, De Vusser K, Vanrenterghem Y.

N Engl J Med. 2013 Nov 7;369(19):1797-806. doi: 10.1056/NEJMoa1301064.

35.

Serum concentrations of p-cresyl sulfate and indoxyl sulfate, but not inflammatory markers, increase in incident peritoneal dialysis patients in parallel with loss of residual renal function.

Viaene L, Meijers BK, Bammens B, Vanrenterghem Y, Evenepoel P.

Perit Dial Int. 2014 Jan-Feb;34(1):71-8. doi: 10.3747/pdi.2012.00276. Epub 2013 Oct 31. Erratum in: Perit Dial Int. 2015 Jul-Aug;35(4):492.

36.

Post-streptococcal glomerulonephritis: not an extinct disease!

Demuynck M, Lerut E, Kuypers D, Evenepoel P, Claes K, Naesens M, Meijers B, Vanrenterghem Y, Bammens B.

Acta Clin Belg. 2013 May-Jun;68(3):215-7.

PMID:
24156223
37.

Aortic calcifications and arterial stiffness as predictors of cardiovascular events in incident renal transplant recipients.

Claes KJ, Heye S, Bammens B, Kuypers DR, Meijers B, Naesens M, Vanrenterghem Y, Evenepoel P.

Transpl Int. 2013 Oct;26(10):973-81. doi: 10.1111/tri.12151. Epub 2013 Jul 19.

38.

Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD.

Poesen R, Viaene L, Verbeke K, Claes K, Bammens B, Sprangers B, Naesens M, Vanrenterghem Y, Kuypers D, Evenepoel P, Meijers B.

Clin J Am Soc Nephrol. 2013 Sep;8(9):1508-14. doi: 10.2215/CJN.00300113. Epub 2013 Jun 27.

39.

Safety and efficacy of different lanreotide doses in the treatment of polycystic liver disease: pooled analysis of individual patient data.

Temmerman F, Gevers T, Ho TA, Vanslembrouck R, Coudyzer W, van Pelt J, Bammens B, Pirson Y, Drenth JP, Nevens F.

Aliment Pharmacol Ther. 2013 Aug;38(4):397-406. doi: 10.1111/apt.12384. Epub 2013 Jun 25.

40.

Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcome.

Vanhove T, Kuypers D, Claes KJ, Evenepoel P, Meijers B, Naesens M, Vanrenterghem Y, Cornelis T, Bammens B.

Transpl Int. 2013 Aug;26(8):813-21. doi: 10.1111/tri.12133. Epub 2013 Jun 10.

41.

Combined kidney and intestinal transplantation in patients with enteric hyperoxaluria secondary to short bowel syndrome.

Ceulemans LJ, Nijs Y, Nuytens F, De Hertogh G, Claes K, Bammens B, Naesens M, Evenepoel P, Kuypers D, Vanrenterghem Y, Monbaliu D, Pirenne J.

Am J Transplant. 2013 Jul;13(7):1910-4. doi: 10.1111/ajt.12305. Epub 2013 Jun 3.

42.

Survival and heart failure therapy in chronic dialysis patients with heart failure and reduced left ventricular ejection fraction: an observational retrospective study.

Derthoo D, Belmans A, Claes K, Bammens B, Ciarka A, Droogné W, Vanhaecke J, Van Cleemput J, Janssens S.

Acta Cardiol. 2013 Feb;68(1):51-7.

PMID:
23457910
43.

Chronic histological damage in early indication biopsies is an independent risk factor for late renal allograft failure.

Naesens M, Kuypers DR, De Vusser K, Vanrenterghem Y, Evenepoel P, Claes K, Bammens B, Meijers B, Lerut E.

Am J Transplant. 2013 Jan;13(1):86-99. doi: 10.1111/j.1600-6143.2012.04304.x. Epub 2012 Nov 8.

44.

Measuring the glomerular filtration rate in different age groups using iohexol, the protocol from the Belgian iohexol study.

Van Pottelbergh G, Hoste L, Degryse J, Pottel H, Claes K, Demoulin N, Jadoul M, Bammens B, Wallemacq P.

Clin Biochem. 2013 Jan;46(1-2):31-6. doi: 10.1016/j.clinbiochem.2012.10.017. Epub 2012 Oct 23.

PMID:
23099194
45.

Multimodality imaging of giant coronary artery aneurysms in immunoglobulin g4-related sclerosing disease.

Debonnaire P, Bammens B, Blockmans D, Herregods MC, Dubois C, Voigt JU.

J Am Coll Cardiol. 2012 Apr 3;59(14):e27. doi: 10.1016/j.jacc.2011.06.085. No abstract available.

46.

Impact of vascular calcification on corrected QT interval at the time of renal transplantation.

Claes KJ, Heye S, Nuyens D, Bammens B, Kuypers DR, Vanrenterghem Y, Evenepoel P.

Am J Nephrol. 2012;35(1):24-30. doi: 10.1159/000334597. Epub 2011 Dec 6.

PMID:
22143191
47.

Residual renal function is an independent determinant of serum FGF-23 levels in dialysis patients.

Viaene L, Bammens B, Meijers BK, Vanrenterghem Y, Vanderschueren D, Evenepoel P.

Nephrol Dial Transplant. 2012 May;27(5):2017-22. doi: 10.1093/ndt/gfr596. Epub 2011 Oct 24.

PMID:
22025115
48.

Mineral metabolism in renal transplant recipients discontinuing cinacalcet at the time of transplantation: a prospective observational study.

Evenepoel P, Sprangers B, Lerut E, Bammens B, Claes K, Kuypers D, Meijers B, Vanrenterghem Y.

Clin Transplant. 2012 May-Jun;26(3):393-402. doi: 10.1111/j.1399-0012.2011.01524.x. Epub 2011 Oct 18.

PMID:
22007637
49.

Prevalence and determinants of anemia in the immediate postkidney transplant period.

Poesen R, Bammens B, Claes K, Kuypers D, Vanrenterghem Y, Monbaliu D, Evenepoel P.

Transpl Int. 2011 Dec;24(12):1208-15. doi: 10.1111/j.1432-2277.2011.01340.x. Epub 2011 Sep 19.

50.

Reduction in protein-bound solutes unacceptable as marker of dialysis efficacy during alternate-night nocturnal hemodialysis.

Meijers B, Toussaint ND, Meyer T, Bammens B, Verbeke K, Vanrenterghem Y, Kerr PG, Evenepoel P.

Am J Nephrol. 2011;34(3):226-32. doi: 10.1159/000330176. Epub 2011 Jul 23.

PMID:
21791919

Supplemental Content

Loading ...
Support Center